Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 7
2021 11
2022 17
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age.
Lisco G, Disoteo OE, De Tullio A, De Geronimo V, Giagulli VA, Monzani F, Jirillo E, Cozzi R, Guastamacchia E, De Pergola G, Triggiani V. Lisco G, et al. Nutrients. 2023 Dec 25;16(1):63. doi: 10.3390/nu16010063. Nutrients. 2023. PMID: 38201893 Free PMC article. Review.
Endocrine-Disrupting Chemicals: Introduction to the Theme.
Lisco G, Giagulli VA, Iovino M, Guastamacchia E, Pergola G, Triggiani V. Lisco G, et al. Endocr Metab Immune Disord Drug Targets. 2022 Aug 15;22(7):677-685. doi: 10.2174/1871530321666210413124425. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 33847259 Review.
Neuroendocrine Modulation of Food Intake and Eating Behavior.
Iovino M, Messana T, Lisco G, Mariano F, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V. Iovino M, et al. Among authors: lisco g. Endocr Metab Immune Disord Drug Targets. 2022;22(13):1252-1262. doi: 10.2174/1871530322666220127114326. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35086464 Review.
Iodine Deficiency and Iodine Prophylaxis: An Overview and Update.
Lisco G, De Tullio A, Triggiani D, Zupo R, Giagulli VA, De Pergola G, Piazzolla G, Guastamacchia E, Sabbà C, Triggiani V. Lisco G, et al. Nutrients. 2023 Feb 16;15(4):1004. doi: 10.3390/nu15041004. Nutrients. 2023. PMID: 36839362 Free PMC article. Review.
Covid-19 in Man: A Very Dangerous Affair.
Lisco G, Giagulli VA, De Pergola G, De Tullio A, Guastamacchia E, Triggiani V. Lisco G, et al. Endocr Metab Immune Disord Drug Targets. 2021;21(9):1544-1554. doi: 10.2174/1871530321666210101123801. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33388025 Review.
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study.
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V, Triggiani D, Crudele L, Triggiani V, Sabbà C, De Pergola G, Piazzolla G. Volpe S, et al. Among authors: lisco g. Front Endocrinol (Lausanne). 2023 Sep 13;14:1240263. doi: 10.3389/fendo.2023.1240263. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37780624 Free PMC article.
Hypothyroidism in older adults: A narrative review.
Fiore V, Barucca A, Barraco S, Triggiani D, Carbotta G, Giagulli VA, Piazzolla G, Lisco G, Triggiani V. Fiore V, et al. Among authors: lisco g. Endocr Metab Immune Disord Drug Targets. 2023 Aug 28. doi: 10.2174/1871530323666230828110153. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37641994
Is Testosterone the "Fountain of Youth" for Aging Men?
Giagulli VA, Lisco G, Mariano F, De Tullio A, Triggiani V. Giagulli VA, et al. Among authors: lisco g. Endocr Metab Immune Disord Drug Targets. 2023;23(2):169-178. doi: 10.2174/1871530322666220516160435. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35578868 Review.
59 results